Expanding business scale through M&A, alliances and product acquisitions
First written in FY2017-Q3. 10 of 19 entries say "Restated". Latest entry: FY2026.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「We began exclusive sales in Japan of BASF products for the fruit tree sector. We also promoted initiatives to create new sources of revenue by filing patent applications through open innovation with RIKEN and investing in 株式会社農研植物病院, a venture originating from NARO.」
The company began exclusive domestic sales of BASF products and advanced the incorporation of external value through alliances and other initiatives, including filing patent applications with RIKEN and investing in 株式会社農研植物病院. - 2026-05-13AdvancedRevision of earnings forecasts
「We also advanced initiatives to create new sources of revenue through patent applications under open innovation with the Center for Sustainable Resource Science at RIKEN, and through an investment in 株式会社農研植物病院, a startup originating from the National Agriculture and Food Research Organization.」
The business portfolio and sources of revenue are expanding through external collaboration and investment, including patent applications with RIKEN and an investment in 株式会社農研植物病院. - FY2026-H1AdvancedAnnual report
「We agreed with BASF Japan Ltd. (hereinafter, “BASF”) to sell products for the fruit tree sector in Japan through exclusive supply under BASF trademarks and registration numbers. We also promoted initiatives to create new sources of revenue, including filing patent applications toward commercialization for the development of production technologies for high-value-added compounds using natural-product-derived raw materials through open innovation with RIKEN's Center for Sustainable Resource Science.」
The disclosure describes progress in expanding business scale and revenue sources through alliances and external collaboration, including the agreement with BASF on exclusive supply and sales and the filing of patent applications through open innovation with RIKEN. - FY2025AdvancedAnnual report
「To expand the business beyond chemical crop protection products, the company acquired rights relating to the registration, development and sale of a new biological fungicide, among other matters.」
As a specific example of expanding business areas through M&A, alliances and the incorporation of external value, the company acquired rights relating to the registration, development and sale of a new biological fungicide, among other matters. - FY2024-Q2RestatedAnnual report
「As a major initiative during the nine-month period of the second quarter of the current fiscal year, Nichino Europe Co., Ltd., a consolidated subsidiary, acquired all issued shares of Interagro (UK) Limited, a UK manufacturer and seller of adjuvants and other additives and biostimulants, with the aim of expanding its business portfolio beyond chemically synthesized crop protection products.」
The company has reconfirmed the expansion of its business portfolio beyond chemically synthesized crop protection products through the acquisition of all issued shares of Interagro. The acquisition itself was already disclosed in the previous quarter. - FY2024-Q1AdvancedAnnual report
「As a key initiative during the cumulative first quarter, Nichino Europe Co., Ltd., a consolidated subsidiary of the company, acquired all issued shares of Interagro (UK) Limited, a UK-based manufacturer and distributor of adjuvants and other additives and biostimulants, with the aim of expanding the business portfolio beyond chemically synthesized pesticides.」
The company carried out a specific M&A transaction by acquiring all issued shares of Interagro, expanding its business portfolio beyond chemically synthesized crop protection products. - FY2022RestatedAnnual report
「The Group will continue to maximize the contribution to earnings from investments and acquisitions completed to date, while expanding its business through the execution of additional growth strategies, with the aim of achieving target sales of ¥100 billion.」
The Group continues to target maximum earnings contributions from existing investments and acquisitions, business expansion through additional growth strategies, and sales of ¥100 billion. - FY2021ReframedAnnual report
「• Expansion into non-chemical crop protection We will leverage the technologies and expertise cultivated through our chemical crop protection business, including the development of pharmaceuticals and animal health products, the introduction of biological crop protection products and biostimulants that support healthy crop growth, businesses using semi-fermentation technology to produce natural substances, and the creation of crops that produce specific functional ingredients, to provide society with new value that contributes to healthy living through the life sciences. We will also consider expanding our business areas as appropriate by incorporating external value through M&A and other means.」
M&A is positioned not only as a means of expanding the existing crop protection business, but also as a means of expanding into next-generation life science areas such as pharmaceuticals and animal health products, biological crop protection products and biostimulants. - FY2020-Q1RestatedAnnual report
「As described above, we have formulated the three-year medium-term management plan “Ensuring Growing Global 2021 (EGG2021): Making Growing Global a certainty!” beginning in fiscal 2019. With “improving profitability” and “strengthening Group capabilities” as its two pillars, we will accelerate the earnings contribution of growth strategies implemented to date and strengthen the foundations for making Growing Global firmly established. In addition, we will continue initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our operations.」
The policy of continuing to expand the business through M&A, alliances and product acquisitions has been reconfirmed as a measure under EGG2021. - FY2019-Q4RestatedAnnual report
「We will continue initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our business.」
M&A, alliances and product acquisitions continue to be pursued as measures under EGG2021 to expand the business. - FY2019-Q3RestatedAnnual report
「We will continue initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our business.」
M&A, alliances and product acquisitions continue to be pursued as measures under EGG2021 to expand the business. No milestone such as completion of a new acquisition is disclosed. - FY2018AdvancedAnnual report
「To achieve this vision, we invested in 株式会社アグリマート, India's Hyderabad Chemical Pvt. Ltd. (now Nichino India Pvt. Ltd.) and Brazil's Sipcam Nichino Brasil S.A.; established a local subsidiary in Vietnam; and made Adnicol in Colombia a subsidiary. Through these initiatives, we achieved a certain level of progress in building a foundation for expanding our business.」
The disclosure describes specific progress in expanding the business base through M&A and investments, including making Adnicol in Colombia a subsidiary. - FY2019-Q1RestatedAnnual report
「As described above, we have formulated the three-year medium-term management plan “Advance to Growing Global 2018 (AGG2018): Advancing toward a global company,” beginning in fiscal 2016. With “promoting the growth strategy” and “improving profitability” as its two pillars, we will pursue initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our operations.」
M&A, alliances and product acquisitions continue to be positioned as means of expanding the business under AGG2018. - FY2018-Q4RestatedAnnual report
「As described above, we have formulated the three-year medium-term management plan “Advance to Growing Global 2018 (AGG2018): Advancing toward a global company,” beginning in fiscal 2016. With “promoting the growth strategy” and “improving profitability” as its two pillars, we will pursue initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our operations.」
M&A, alliances and product acquisitions continue to be positioned as means of expanding the business under AGG2018. - FY2018-Q3RestatedAnnual report
「As described above, we have formulated the three-year medium-term management plan “Advance to Growing Global 2018 (AGG2018): Advancing toward a global company,” beginning in fiscal 2016. With “promoting the growth strategy” and “improving profitability” as its two pillars, we will pursue initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our operations.」
M&A, alliances and product acquisitions continue to be positioned as means of expanding the business under AGG2018. - FY2017AdvancedAnnual report
「September 2017: Acquired an additional 25.94% of the issued shares of Hyderabad Chemical Pvt. Ltd.」
The disclosure describes progress in a specific acquisition and investment, namely the additional acquisition of shares in HCL. - FY2018-Q1RestatedAnnual report
「As described above, we have formulated the three-year medium-term management plan “Advance to Growing Global 2018 (AGG2018): Advancing toward a global company,” beginning in fiscal 2016. With “promoting the growth strategy” and “improving profitability” as its two pillars, we will pursue initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our operations.」
M&A, alliances and product acquisitions continue to be positioned as means of expanding the business under AGG2018. - FY2017-Q4RestatedAnnual report
「As described above, we have formulated the three-year medium-term management plan “Advance to Growing Global 2018 (AGG2018): Advancing toward a global company,” beginning in fiscal 2016. With “promoting the growth strategy” and “improving profitability” as its two pillars, we will pursue initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our operations.」
M&A, alliances and product acquisitions continue to be positioned as means of expanding the business under AGG2018. - FY2017-Q3First statedAnnual report
「We will carry out initiatives to expand the business, including M&A, alliances and product acquisitions, and expand the scale of our business.」
M&A, alliances and product acquisitions are explicitly identified as specific means of expanding the business under AGG2018.